Bayer Diagnostics And Innogenetics Launch Versant HCV Genotype 2.0 Assay (LiPA) For Hepatitis C Virus Genotyping

Thu, 23 Nov 2006 02:00 PM EST

... Bayer HealthCare, Diagnostics Division, a member of the Bayer Group (NYSE:BAY) and Innogenetics N.V. announced today that the VERSANT® HCV (Hepatitis C Virus) Genotype 2.0 Assay (LiPA) has been released for sale in Europe. This next generation hepatitis C assay is an upgrade of Bayer's VERSANT HCV Genotype 1. [click link for full article] ...